Association Briefs

A look at the top stories in physics this past year according to Physics News in 1989 reveals one conspicuous absence - cold fusion. Why was one of science's most fiercely debated issues of the year not included? Phillip Schewe, editor of the American Institute of Physics' annual review, says there simply was not enough confirming evidence. Last spring, when the cold fusion issue was contested by physicists attending the American Physical Society meeting in Baltimore, there was a pervasive feel

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A look at the top stories in physics this past year according to Physics News in 1989 reveals one conspicuous absence - cold fusion. Why was one of science's most fiercely debated issues of the year not included? Phillip Schewe, editor of the American Institute of Physics' annual review, says there simply was not enough confirming evidence. Last spring, when the cold fusion issue was contested by physicists attending the American Physical Society meeting in Baltimore, there was a pervasive feeling from APS members that "those guys in Utah didn't know what they were doing," says Schewe, referring to claims made by the University of Utah's B. Stanley Pons and Martin Fleischmann. "I would have to support them [APS members] in their view."

The stories included in Physics News in 1989, this year published as a separate booklet, were chosen by scientists from AIP's 10 member societies. Other topics in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies